144P: Oligometastatic non-small-cell lung cancer (NSCLC) and unresectable primary tumor: Updated retrospective analysis of safety and efficacy of the radical treatment for the primary tumor and the metastases.


143PD Bevacizumab and pemetrexed versus pemetrexed alone as maintenance therapy for patients with advanced nonsquamous NSCLC: Results of the expanded SAKK19/09 trial O. Gautschi1, Q. Li2, K. Matter-Walstra3, D. Betticher4, M. Frueh5, D. Rauch6, M. Pless7, P. Froesch8, N. Mach9, A. Ochsenbein10. 1Medizinische Onkologie, Luzerner Kantonsspital, Luzern… (More)
DOI: 10.1016/S1556-0864(16)30254-4